A case of hemiballism as a rare side effect of ciprofloxacin in a patient with liver cirrhosis

Chemotherapy

Volumn 55, Issue 4, 2009, Pages 207-210

  Kim, Su Hyun ^a   Jeong, Sook Hyang ^a   Kim, Jin Wook ^a   Lee, Sang Hyub ^a   Kim, Jong Min ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adverse effects of ciprofloxacin; Ciprofloxacin; Hemiballism; Liver cirrhosis

Indexed keywords

CIPROFLOXACIN; FUROSEMIDE; HALOPERIDOL; LACTULOSE; LAMIVUDINE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPIRONOLACTONE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; CASE REPORT; CONSTIPATION; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEMIBALLISM; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; INVOLUNTARY MOVEMENT; KIDNEY ABSCESS; LIVER CIRRHOSIS; NEUROLOGIC DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

CIPROFLOXACIN; DYSKINESIA, DRUG-INDUCED; FEMALE; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED;

EID: 65549091110     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218098     Document Type: Article

References (23)

1. Domagala JM: Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994;33:685-706.
2. Owens RC, Ambrose PG: Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 2005;41(suppl 2):144-157.
3. Kayabas U, Yetkin F, Firat AK, Ozcan H, Bayindir Y: Ciprofloxacin-induced urticaria and tenosynovitis: A case report. Chemotherapy 2008;54:288-290.
4. Lipsky BA, Baker CA: Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999;28:352-364.
5. Stahlmann R: Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 2002;127:269-277.
6. Azar S, Ramjiani A, Van Gerpen JA: Ciprofloxacin-induced chorea. Mov Disord 2005;20:513-514; author reply 514.
7. Reeves RR: Ciprofloxacin-induced psychosis. Ann Pharmacother 1992;26:930-931.
8. Walton GD, Hon JK, Mulpur TG: Ofloxacin-induced seizure. Ann Pharmacother 1997;31:1475-1477.
9. Moretti MV, Pauluzzi S, Cesana M: Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges. Antimicrob Agents Chemother 2000;44:73-77.
10. Bowie WR, Willetts V, Jewesson PJ: Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrob Agents Chemother 1989;33:1778-1782.
11. Yamaguchi H, Kawai H, Matsumoto T, Yokoyama H, Nakayasu T, Komiya M, Shimada J: Post-marketing surveillance of the safety of levofloxacin in Japan. Chemotherapy 2007;53:85-103.
12. Schwartz MT, Calvert JF: Potential neurologic toxicity related to ciprofloxacin. Dicp 1990;24:138-140.
13. Rollof J, Vinge E: Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDs, and chloroquine: possible drug interaction. Ann Pharmacother 1993;27:1058-1059.
14. Nakamura T, Fukuda H, Morita Y, Soumi K, Kawamura Y: Pharmacological evaluation of garenoxacin, a novel des-f(6)-quinolone antimicrobial agent: effects on the central nervous system. J Toxicol Sci 2003;28:35-45.
15. Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B: Levofloxacin-induced delirium with psychotic features. Gen Hosp Psychiatry 2008;30:381-383.
16. Akahane K, Sekiguchi M, Une T, Osada Y: Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989;33:1704-1708.
17. Semel JD, Allen N: Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole. South Med J 1991;84:465-468.
18. Kushner JM, Peckman HJ, Snyder CR: Seizures associated with fluoroquinolones. Ann Pharmacother 2001;35:1194-1198.
19. Schmuck G, Schurmann A, Schluter G: Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother 1998;42:1831-1836.
20. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J: Guidelines for the selection of anti-infective agents for complicated intraabdominal infections. Clin Infect Dis 2003;37:997-1005.
21. Bellmann R, Egger P, Gritsch W, Bellmann-Weiler R, Joannidis M, Dunzendorfer S, Wiedermann Ch J: Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. Acta Med Austriaca 2002;29:112-116.
22. Montay G, Gaillot J: Pharmacokinetics of fluoroquinolones in hepatic failure. J Antimicrob Chemother 1990;26(suppl B):61-67.
23. Lode H, Hoffken G, Boeckk M, Deppermann N, Borner K, Koeppe P: Quinolone pharmacokinetics and metabolism. J Antimicrob Chemother 1990;26(suppl B):41-49